Journal of Literature Pharmacy Sciences

.: REVIEW
Hiyalüronik Asit ve Tıbbi Önemi
Hyaluronic Acid and Medicinal Importance
Büşra FENDOĞLUa, Didem ŞÖHRETOĞLUa, Ayşe KURUÜZÜM UZa
aFarmakognozi AD, Hacettepe Üniversitesi Eczacılık Fakültesi, Ankara, TÜRKİYE
J Lit Pharm Sci. 2019;8(1):76-84
doi: 10.5336/pharmsci.2018-62742
Article Language: TR
Full Text
ÖZET
 Hiyalüronik asit; omurgalıların epitelyal, nöral ve bağ dokularının hücre dışı matrisinde bulunan bir polisakkarittir. Yüksek nem tutma, biyouyumluluk ve viskoelastisite özellikleri nedeni ile dünya çapında yüksek ticari değeri olan çeşitli farmasötik, biyomedikal ve kozmetik ürünlerin önemli bir bileşeni hâline gelmiştir. Günümüzde antiinflamatuar ve antiödem özelliklerinden dolayı oftalmoloji, dermatoloji, ortopedi ve romatoloji alanlarında sıklıkla kullanılmakta olup, son zamanlarda diş hekimliğinde de kullanımı bulunmaktadır.

Anahtar Kelimeler: Hiyalüronik asit; biyolojik ürün; glikozaminoglikan
ABSTRACT
 Hyaluronic acid is a polysaccharide found in the extracellular matrix of the epithelial, neural, and connective tissues of the vertebrates. Because of its high moisture retention, biocompatibility and viscoelastic properties, this polymer has become a major component of major pharmaceutical, biomedical and cosmetic products with high commercial value worldwide. Due to its antiinflammatory and anti-edematous properties today, it is frequently used in ophthalmology, dermatology, orthopedics and rheumatology fields and has also recently been used in dentistry.

Keywords: Hyaluronic acid; biological products; glycosaminoglycans
REFERENCES:
  1. Meyer K, Palmer JW. The polysaccharide of the vitreous humor. J Biol Chem. 1934;107:629-34.
  2. Balazs EA, Laurent TC, Jeanloz RW. Nomenclature of hyaluronic acid. Biochem J. 1986;235(3):903. [Crossref] [PMC]
  3. Scott JE, Heatley F. Hyaluronan forms specific stable tertiary structures in aqueous solution: a C-13 NMR study. Proc Natl Acad Sci U S A. 1999;96(9):4850-5. [Crossref]
  4. Beasley KL, Weiss MA, Weiss RA. Hyaluronic acid fillers: a comprehensive review. Facial Plast Surg. 2009;25(2):86-94. [Crossref]
  5. Tsepilov RN, Beloded AV. Hyaluronic acid-an ? old ? molecule with ? new ? functions: biosynthesis and depolymerization of hyaluronic acid in bacteria and vertebrate tissues including during carcinogenesis. Biochem (Mosc). 2015;80(9):1093-108. [Crossref]
  6. Heldermon C, DeAngelis PL, Weigel PH. Topological organization of the hyaluronan synthase from Streptococcus pyogenes. J Biol Chem. 2001;276(3):2037-46. [Crossref]
  7. Bernstein EF, Underhill CB, Hahn PJ, Brown DB, Uitto J. Chronic sun exposure alters both the content and distrbution of dermal glicosaminoglicans. Br J Dermatol. 1996;135(2): 255-62. [Crossref]
  8. Leach JB, Schmidt CE. Hyaluronan. In: Wnek GE, Bowlin GL, eds. Encyclopedia of Biomaterials and Biomedical Engineering. 1 st ed. New York: Marcel Dekker; 2004. p.779-89.
  9. Mio K, Stern R. Inhibitors of the hyaluronidases. Matrix Biol. 2002;21(1):31-7. [Crossref]
  10. Ponnuraj K, Jedrzejas MJ. Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 A resolution. J Mol Biol. 2000;299(4):885-95. [Crossref]
  11. Lokeshwar VB, Schroeder GL, Carey RI, Soloway MS, Iida N. Regulation of hyaluronidase activity by alternative mRNA splicing. J Biol Chem. 2002;277(37):33654-63. [Crossref]
  12. El Hajjaji H, Cole AA, Manicourt DH. Chondrocytes, synoviocytes and dermal fibroblasts all express PH-20, a hyaluronidase active at neutral pH. Arthritis Res Ther. 2005;7(4): R756-68. [Crossref]
  13. Girish KS, Kemparaju K. Inhibition of Naja naja venon hyaluronidase: role in the management of poisonous bite. Life Sci. 2005;78(13):1433-40. [Crossref]
  14. Kim E, Baba D, Kimura M, Yamashita M, Kashiwabara S, Baba T. Identification of a hyaluronidase, Hyal5, involved in penetration of mouse sperm through cumulus mass. Proc Nat Acad of Sci U S A. 2005;102(50):1802833. [Crossref]
  15. Senni K, Pereira J, Gueniche F, DelbarreLadrat C, Sinquin C, Ratiskol J, et al. Marine polysaccharides: a source of bioactive molecules for cell therapy and tissue engineering. Mar Drugs. 2011;9(9):1664-81. [Crossref]
  16. Giji S, Arumugam M. Isolation and characterization of hyaluronic acid from marine organisms. Adv Food Nutr Res. 2014;72:61-77. [Crossref]
  17. Balazs EA, Band P. Hyaluronic acid: its structure and use. Cosmet Toilet. 1984;99:65-72.
  18. Brown MB, Jones SA. Hyaluronic acid: a unique topikal vehicle for the localized delivery of drugs to the skin. J Eur Acad Dermatol Venereol. 2005;19(3):308-18. [Crossref]
  19. Kang DY, Kim WS, Heo IS, Park YH, Lee S. Extraction of hyaluronic acid (HA) from rooster comb and characterization using flow fieldflow fractionation (FlFFF) coupled with multiangle light scattering (MALS). J Sep Sci. 2010;33(22):3530-6. [Crossref]
  20. Hadidian Z, Pirie NW. The preparation and some properties of hyaluronic acid from human umbilical cord. Biochem J. 1948;42(2):260-5. [Crossref]
  21. Balazs EA, Watson D, Duff IF, Roseman S. Hyaluronic acid in synovial fluid. I. molecular parameters of hyaluronic acid in normal and arthritic human fluids. Artritis Rheum. 1967;10(4):357-76. [Crossref]
  22. Nishikawa S, Tamai M. Ultrastructure of hyaluronic acid and collagen in the human vitreous. Curr Eye Res. 1996;15(1):37-43. [Crossref]
  23. Postlethwaite AE, Smith GN Jr, Lachman LB, Endres RO, Poppleton HM, Hasty KA, et al. Stimulation of glycosaminoglycan synthesis in cultured human dermal fibroblasts by interleukin 1. Induction of hyaluronic acid synthesis by natural and recombinant interleukin 1s and synthetic interleukin 1 beta peptide 163-171. J Clin Invest. 1989;83(2):629-36. [Crossref]
  24. Akiyama H, Saito M, Qiu G, Toida T, Imanari T. Analytical studies on hyaluronic acid synthesis by normal human epidermal keratinocytes cultured in a serum-free medium. Biol Pharm Bull. 1994;17(3):361-4. [Crossref]
  25. Toyoda H, Motoki K, Tanikawa M, Shinomiya K, Akiyama H, Imanari T. Determination of human urinary hyaluronic acid, chondroitin sulphate and dermatan sulphate as their unsaturated disaccharides by high-performance liquid chromatography. J Chromatogr. 1991;565(1-2):141-8. [Crossref]
  26. Deutsch HF. Some properties of a human serum hyaluronic acid. J Biol Chem. 1957;224(2):767-74.
  27. Nettelbladt O, Bergh J, Schenholm M, Tengblad A, Hällgren R. Accumulation of hyaluronic acid in the alveolar interstitial eritissue in bleomycin-induced alveolitis. Am Rev Respir Dis. 1989;139(3):759-62. [Crossref]
  28. Hallgren R, Gerdin B, Tufveson G. Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft. Relationship to the transplantation edema. J Exp Med. 1990;171(6): 2063-76. [Crossref]
  29. Bignami A, Asher R. Some observations on the localization of hyaluronic acid in adult, newborn and embryonal rat brain. Int J Develop Neurosci. 1992;10(1):45-57. [Crossref]
  30. Fraser JR, Alcorn D, Laurent TC, Robinson AD, Ryan GB. Uptake of circulating hyaluronic acid by the rat liver. Cellular localization in situ. Cell Tissue Res. 1985;242(3):505-10. [Cross ref]
  31. Kuhlman RE, Kaufman HE. A microchemical study of the aqueous humor enzyme-protein interrelations. Arch Ophthalmol. 1960;63(1):41-6. [Crossref]
  32. Cleland RL, Sherblom AP. Isolation and physical characterization of hyaluronic acid prepared from bovine nasal septum by cetylpyridinium chloride precipitation. J Biol Chem. 1977; 252(2):420-6.
  33. Fraser JR, Kimpton WG, Pierscionek BK, Cahill RN. The kinetics of hyaluronan in normal and acutely inflamed synovial joints: observations with experimental arthritis in sheep. Semin Arthritis Rheum. 1993;6 Suppl 1:9-17. [Crossref]
  34. Dicker SE, Franklin CS. The isolation of hyaluronic acid and chondroitin sulphate from kidneys and their reaction with urinary hyaluronidase. J Physiol. 1996;186(1):110-20. [Crossref]
  35. Lebel L, Smith L, Risberg B, Gerdin B, Laurent TC. Effect of increased hydrostatic pressure on lymphatic elimination of hyaluronan from sheep lung. J App Physiol. (1985) 1988;64(4):1327-32. [Crossref]
  36. Farber SJ, vag Praag D. Composition of glycosaminoglycans (mucopolysaccharides) in rabbit renal papillae. Biochim Biophys Acta. 1970;208(2):219-26. [Crossref]
  37. Necas J, Bartosikova L, Brauner P, Kolar J. Hyaluronic acid (hyaluronan): a review. Vet Med. 2008;53(8):397-411. [Crossref]
  38. Dwyer TM, Banks SA, Alonso-Galicia M, Cockrell K, Carroll JF, Bigler SA, et al. Distribution of renal medullary hyaluronan in lean and obese rabbits. Kidney Int. 2000;58(2):7219. [Crossref]
  39. Takagaki K, Nakamura T, Majima M, Endo M. Isolation and characterization of a chondroitin sulfate-degrading endo-beta-glucuronidase from rabbit liver. J Biol Chem. 1988;263(15): 7000-6.
  40. Laurent UB, Fraser JR. Turnover of hyaluronate in the aqueous humour and vitreous body of the rabbit. Exp Eye Res. 1983;36(4):493-503. [Crossref]
  41. Seastone CV. The virulence of group C haemolytic streptococci of animal origin. J Exp Med. 1939;70(4):361-78. [Crossref]
  42. Aslan M, Simsek G, Dayi E. The effect of hyaluronic acid-supplemented bone graft in bone healing: experimental study in rabbits. J Biomater Appl. 2006;20(3):209-20. [Crossref]
  43. Çakır O, Kazancıoğlu HO, Ak G. [Hyaluronic acid in dentistry]. Istanbul Univ Dishekim Fak Derg. 2011;45(1):37-41.
  44. Turley EA, Noble PW, Bourguignon LY. Signaling properties of hyaluronan receptors. J Biol Chem. 2002;277(7):4589-92. [Crossref]
  45. Hascall VC, Majors AK, De la Motte CA, Evanko SP, Wang A, Drazba JA, et al. Intra cellular hyaluronan: a new frontier for inflammation? Biochim Biophys Acta. 2004; 1673(1-2):3-12. [Crossref]
  46. Sutherland IW. Novel and established applications ofmicrobial polysaccharides. Trends Biotechnol. 1998;16(1):41-6. [Crossref]
  47. Liao YH, Jones SA, Forbes B, Martin GP, Brown MB. Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv. 2005;12(6):327-42. [Crossref]
  48. Simon A, Safran A, Revel A, Aizenman E, Reubinoff B, Porat-Katz A, et al. Hyaluronic acid can successfully replace albumin as the sole macromolecule in a human embryo transfer medium. Fertil Steril. 2003;79(6):1434-8. [Crossref]
  49. Gardner DK, Rodriegez-Martinez H, Lane M. Fetal development after transfer is increased by replacing protein with the glycosaminoglycan hyaluronan for mouse embryo culture and transfer. Hum Reprod. 1999;14(10):2575-80. [Crossref]
  50. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;20:3-9.
  51. Ghosh S, Jassal M. Use of polysaccharide fibres for modem wound dressings. Ind J Fibre Textile Res. 2002;27:434-50.
  52. Lequeux I, Ducasse E, Jouenne T, Thebault P. Addition of antimicrobial properties to hyaluronic acid by grafting of antimicrobial peptide. Eur Polym J. 2014;51:182-90. [Crossref]
  53. Barbucci R, Magnani A, Casolaro M, Marchettini N, Rosi C, Bosco M. Modification of hyaluronic acid by insertion of sulfate groups to obtain a heparinlike molecule. Part I. Characterization and behavior in aqueous solution towards H+ and Cu2+ ions. Gazz Chim Ital. 1995;125:169-80.
  54. Wu RL, Huang L, Zhao HC, Geng XP. Hyaluronic acid in digestive cancers. J Cancer Res Clin Oncol. 2017;143(1):1-16. [Crossref]
  55. Kim JH, Moon MJ, Kim DY, Heo SH, Jeong YY. Hyaluronic acid-based nanomaterials for cancer therapy. Polymers. 2018;10(10):1133. [Crossref]
  56. Scaife CL, Shea JE, Dai Q, Firpo MA, Prestwich GD, Mulvihill SJ. Synthetic extracellular matrix enhances tumor growth and metastasis in an orthotopic mouse model of pancreatic adenocarcinoma. J Gastrointest Surg. 2008;12(6):1074-80. [Crossref]
  57. Seufferlein T, Ducreux M, Hidalgo M, Prager G, Van Cutsem E. More than a gelhyaluronic acid, a central component in the microenvironment of pancreatic cancer. European Oncology & Haematology. 2018;14(1):40-4. [Crossref]
  58. Golshani R, Lopez L, Estrella V, Kramer M, Iida N, Lokeshwar VB. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. Cancer Res. 2008;68(2):483-91. [Crossref]
  59. Bullard KM, Kim HR, Wheeler MA, Wilson CM, Neudauer CL, Simpson MA, et al. Hyaluronan synthase-3 is upregulated in metastatic colon carcinoma cells and manipulation of expression alters matrix retention and cellular growth. Int J Cancer. 2003;107(5):739-46. [Crossref]
  60. Kim HR, Wheeler MA, Wilspn CM, Iida J, Eng D, Simpson MA, et al. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res. 2004;64(13):4569-76. [Crossref]
  61. Gao F, Liu Y, He Y, Yang C, Wang Y, Shi X, et al. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol J. 2010;29(2):107-16. [Crossref]
  62. Liu D, Pearlman E, Diaconu E, Guo K, Mori H, Haqqi T, et al. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci U S A. 1996;93(15):7832-7. [Crossref]
  63. Guo LX, Zou K, Ju JH, Xie H. Hyaluronan promotes tumor lymphangiogenesis and intralymphantic tumor growth in xenografts. Acta Biochim Biophys Sin (Shanghai). 2005;37(9): 601-6. [Crossref]
  64. Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P, et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol. 2000;165(4):1863-70. [Crossref] [PubMed]
  65. David-Raoudi M, Tranchepain F, Deschrevel B, Vincent JC, Bogdanowicz P, Boumediene K, et al. Differential effects of hyaluronan and its fragments fibroblasts: relation to wound healing. Wound Repair Regen. 2008;16(2):274-87. [Crossref] [PubMed]
  66. Sugahara KN, Hirata T, Hayasaka H, Stern R, Murai T, Miyasaka M. Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments. J Biol Chem. 2006;281(9):5861-8. [Crossref]
  67. Kultti A, Zhao C, Singha NC, Zimmerman S, Osgood RJ, Symons R, et al. Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment. BioMed Res Int. 2014;2014:817613. [Crossref]
  68. Shen YN, Shin HJ, Joo HY, Park ER, Kim SH, Hwang SG, et al. Inhibition of HAS2 induction enhances the radiosensitivity of cancer cells via persistent DNA damage. Biochem Biophys Res Commun. 2014;443(3):796-801. [Crossref]
  69. Ju SY, Chiou SH, Su Y. Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression. Stem Cell Res. 2014;12(1):86-100. [Crossref]
  70. Kavasi RM, Berdiaki A, Spyridaki I, Corsini E, Tsatsakis A, Tzanakakis G, at al. HA metabolism in skin homeostasis and inflammatory disease. Food Chem Toxicol. 2017;101:128-38. [Crossref]
  71. de Maio M. The minimal approach: an innavation in facial cosmetic prosedures. Aesthetic Plast Surg. 2004;28(5):295-300. [Crossref]
  72. Jansen K, van der Werff JF, van Wachem PB, Nicolai JP, de Leij LF, van Luyn MJ. A hyaluronan-based nerve guide: in vitro cytotoxicity, subcutaneous tissue reactions, and degradation in the rat. Biomaterials. 2004;25(3):483-9. [Crossref]
  73. Amarnath LP, Srinivas A, Ramamurthi A. In vitro hemocompatibility testing of UV-modified hyaluronan hydrogels. Biomaterials. 2006; 27(8):1416-24. [Crossref]
  74. Lim YJ, Sim WS, Kim YC, Lee SC, Choi YL. The neurotoxicity of epidural hyaluronic acid in rabbits: a light and electron microscopic examination. Anesth Analg. 2003;97(6):1716-20. [Crossref]

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com